Clinical trial
Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive…
NCT00297778 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00297778 |
|---|---|
| Title | Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms |
| Official title | A Randomized, Double-blind, Placebo-controlled, Parallel Group Efficacy Study of Pramipexole and Placebo Administered Orally Over a 12 Week Treatment Phase in Parkinson's Disease Patients With Stable Motor Function and Depressive Symptoms |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Parkinson Disease, Depression |
| Intervention type | Drug, Other |
| Interventions | Pramipexole, Placebo |
| Enrollment | 296 |
| Start date | Mar 1, 2006 |
| Primary completion | May 1, 2008 |
| First posted | Mar 1, 2006 |
| Last update posted | Jun 9, 2014 |
| Countries | Austria, Finland, France, Germany, Italy, Netherlands, Norway, Romania, Russia, South Africa, Spain, Sweden and 1 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: